Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Central Admixture Pharmacy Services, Inc.
483
•Central Admixture Pharmacy Services, Inc.•January 21, 2016

Central Admixture Pharmacy Services, Inc. – FDA 483, Jan 21, 2016

Record Details

This FDA Form 483 document outlines several significant observations made during an inspection, indicating deficiencies in the facility's manufacturing and quality control processes for drug products, particularly those purporting to be sterile.

Key observations include: 1. **Equipment and Utensil Maintenance:** Equipment and utensils are not maintained at appropriate intervals, which could lead to contamination affecting the safety, identity, strength, quality, or purity of the drug product. 2. **Sterilization Process Validation:** Procedures designed to prevent microbiological contamination of sterile drug products lack adequate validation of the sterilization process. This is a critical deficiency for sterile manufacturing. 3. **Product Release Testing:** The testing and release of drug products for distribution do not include appropriate laboratory determination of satisfactory conformance to final specifications prior to release, raising concerns about product quality and safety reaching the market. 4. **Personnel Clothing:** The clothing worn by personnel engaged in processing drug products is not appropriate for their duties, which could compromise product integrity, especially in aseptic environments. 5. **Aseptic Area Cleaning:** Aseptic processing areas are deficient concerning the system for cleaning and disinfecting the room to produce aseptic conditions, directly impacting the sterility assurance of the products manufactured.

These observations collectively point to significant issues within the facility's quality system, manufacturing controls, and aseptic processing practices, indicating potential risks to drug product quality, safety, and efficacy.

Company
Central Admixture Pharmacy Services, Inc.
Inspection date
January 21, 2016
Product type
Drugs
Office
Cincinnati District Office
People
  • Nicholas L. Paulin
  • Michael P. Sheehan (General Manager)
View Company Profile

ID · f6636f70-ad76-452c-aed5-30723c81d482

Other documents for Central Admixture Pharmacy Services, Inc.
  • 483 - 2023-08-25August 25, 2023
  • 483 - 2021-05-24May 24, 2021
  • 483 - 2018-09-11September 11, 2018
  • 483 - 2014-08-08August 8, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Central Admixture Pharmacy Services, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.